For the top 5 upregulated candidate lncRNAs, the expressions of lncRNA CES1P1 (P = .007), lncRNA RP4‐576H24.2 (P < .001), and lncRNA SIGLEC16 (P = .003) were elevated in AML patients compared with those in controls; however, no difference of lncRNA LINC01262 (P = .122) or lncRNA OR7E140P (P = .662) expressions was found between AML patients and controls (Figure 6A). Here, CES1P1 is linked to acute myeloid leukemia.